Zentalis Pharmaceuticals Inc

NASDAQ:ZNTL   3:59:58 PM EDT
78.15
+4.74 (+6.46%)
Earnings Announcements

Zentalis Pharmaceuticals Reports Third Quarter 2021 Financial Results And Operational Update

Published: 11/10/2021 12:12 GMT
Zentalis Pharmaceuticals Inc (ZNTL) - Zentalis Pharmaceuticals Reports Third Quarter 2021 Financial Results and Operational Update.
Zentalis Pharmaceuticals Inc - Net Loss Was $10.5 Million for Three Months Ended September 30, 2021.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.19

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.24

More details on our Analysts Page.